6.555
price up icon3.39%   0.215
 
loading

Organon Co Borsa (OGN) Ultime notizie

pulisher
07:01 AM

The Escalator: Organon, Kenvue, Real Chemistry and more - Medical Marketing and Media

07:01 AM
pulisher
05:01 AM

Jim Cramer’s “Worst Stock Ever” Might Be Organon (OGN) - Insider Monkey

05:01 AM
pulisher
02:53 AM

Co. (7XP) stock in 20252025 Sector Review & Safe Entry Point Alerts - newser.com

02:53 AM
pulisher
Oct 29, 2025

Organon (OGN) Price Target Decreased by 15.36% to 11.05 - Nasdaq

Oct 29, 2025
pulisher
Oct 29, 2025

MoonLake Immunotherapeutics (MLTX) Faces Securities Class Action After Company Reported Disastrous Phase 3 Trial Data For Sole Drug Candidate -- Hagens Berman - GlobeNewswire Inc.

Oct 29, 2025
pulisher
Oct 29, 2025

Organon & Co. (NYSE:OGN) Given Average Rating of "Hold" by Brokerages - MarketBeat

Oct 29, 2025
pulisher
Oct 29, 2025

Organon: Critical Assessment Of The Audit Committee Investigation Results (NYSE:OGN) - Seeking Alpha

Oct 29, 2025
pulisher
Oct 29, 2025

Organon & Co. (NYSE:OGN) Shares Down 6.2% Following Analyst Downgrade - MarketBeat

Oct 29, 2025
pulisher
Oct 29, 2025

Organon Looks For New CEO Amid Investigation Into Front-Loading Contraceptive Implant Sales - Citeline News & Insights

Oct 29, 2025
pulisher
Oct 29, 2025

Organon (OGN) Is Down 26.2% After CEO Resignation and Audit Reveals Sales Practice Issues – What's Changed - simplywall.st

Oct 29, 2025
pulisher
Oct 29, 2025

Peregrine Capital Management LLC Increases Stock Position in Organon & Co. $OGN - MarketBeat

Oct 29, 2025
pulisher
Oct 29, 2025

D.A. Davidson & CO. Sells 50,248 Shares of Organon & Co. $OGN - MarketBeat

Oct 29, 2025
pulisher
Oct 28, 2025

Why Organon (OGN) Stock Is Down Today - TradingView

Oct 28, 2025
pulisher
Oct 28, 2025

Organon’s Stock Tumbles Amidst Leadership Shake-Up - StocksToTrade

Oct 28, 2025
pulisher
Oct 28, 2025

Organon hit hard over ousted CEO scandal - The Pharma Letter

Oct 28, 2025
pulisher
Oct 28, 2025

The Bottom Fishing ClubOrganon: Deep Value In Drugs/Medical Products (NYSE:OGN) - Seeking Alpha

Oct 28, 2025
pulisher
Oct 28, 2025

Organon & Co. (NYSE:OGN) Hits New 52-Week Low After Analyst Downgrade - MarketBeat

Oct 28, 2025
pulisher
Oct 28, 2025

Organon Investigation Initiated By Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates Claims On Behalf of Investors of Organon & Co.OGN - FinancialContent

Oct 28, 2025
pulisher
Oct 28, 2025

Organon Investor Alert: CEO Resigns Amid Audit ProbeSecurities Fraud Investigation on Behalf of Organon InvestorsContact Kehoe Law Firm, P.C.OGN - ACCESS Newswire

Oct 28, 2025
pulisher
Oct 28, 2025

Morgan Stanley Maintains Organon & Co(OGN.US) With Hold Rating, Maintains Target Price $10 - 富途牛牛

Oct 28, 2025
pulisher
Oct 28, 2025

Organon’s Stock Sinks, But Deep Value Beckons For Patient Investors - Finimize

Oct 28, 2025
pulisher
Oct 28, 2025

Organon & Co stock hits 52-week low at 7.26 USD - Investing.com Australia

Oct 28, 2025
pulisher
Oct 28, 2025

Organon makes personnel moves after internal probe finds ‘improper’ sales practices - ROI-NJ

Oct 28, 2025
pulisher
Oct 27, 2025

Organon appoints interim CEO amid sales practice investigation By Investing.com - Investing.com Canada

Oct 27, 2025
pulisher
Oct 27, 2025

Organon & Co.’s Promising Phase 3 Study on Tapinarof Cream for Pediatric Plaque Psoriasis - TipRanks

Oct 27, 2025
pulisher
Oct 27, 2025

Organon & Co. (OGN) Faces Investor Scrutiny Amid Improper - GlobeNewswire

Oct 27, 2025
pulisher
Oct 27, 2025

Kaplan Fox is Investigating Organon & Co. (OGN) Following an Announcement of Findings of an Audit Committee Investigation and CEO Resignation - NewMediaWire

Oct 27, 2025
pulisher
Oct 27, 2025

Organon CEO resigns after probe into 'improper' sales practices - FirstWord Pharma

Oct 27, 2025
pulisher
Oct 27, 2025

Biotech Outshines As Healthcare Stocks See Mixed Moves - Finimize

Oct 27, 2025
pulisher
Oct 27, 2025

This Drugmaker Made ‘Improper’ Sales to Meet Guidance. The Stock Plummets 22%. - Barron's

Oct 27, 2025
pulisher
Oct 27, 2025

Organon CEO resigns amid Nexplanon sales probe (updated) - NJBIZ

Oct 27, 2025
pulisher
Oct 27, 2025

Organon CEO stands down amid contraceptive sales malpractice probe - Yahoo Finance

Oct 27, 2025
pulisher
Oct 27, 2025

Stocks making the biggest moves midday: Qualcomm, Fermi, Dyne Therapeutics, Organon, Snowflake and more - CNBC

Oct 27, 2025
pulisher
Oct 27, 2025

This Drugmaker Made ‘Improper’ Sales to Meet Guidance. The Stock Plummets 25%. - Barron's

Oct 27, 2025
pulisher
Oct 27, 2025

Piper Sandler Downgrades Organon to Underweight From Overweight, $5 Price Target - MarketScreener

Oct 27, 2025
pulisher
Oct 27, 2025

Organon Appoints Interim CEO and Board Chair; Reports Results of Audit Committee Investigation - New Jersey Business Magazine

Oct 27, 2025
pulisher
Oct 27, 2025

Organon cut to Underweight at Piper Sandler on internal control concerns - Seeking Alpha

Oct 27, 2025
pulisher
Oct 27, 2025

Organon Appoints Company Executive Joseph Morrissey as Interim CEO - citybiz

Oct 27, 2025
pulisher
Oct 27, 2025

Organon & Co stock hits 52-week low at 7.26 USD By Investing.com - Investing.com South Africa

Oct 27, 2025
pulisher
Oct 27, 2025

Organon CEO Resigns After Probe Finds Improper Sales Practices - Bloomberg.com

Oct 27, 2025
pulisher
Oct 27, 2025

Organon appoints company executive Joseph Morrissey as interim CEO and board chair Carrie Cox as executive chair; announces results of audit committee investigation - MarketScreener

Oct 27, 2025
pulisher
Oct 27, 2025

Organon Appoints Company Executive Joseph Morrissey As Interim CEO And Board Chair Carrie Cox As Executive Chair Announces Results Of Audit Committee Investigation - TradingView

Oct 27, 2025
pulisher
Oct 27, 2025

Organon CEO Kevin Ali to resign after probe into contraceptive sales - Reuters

Oct 27, 2025
pulisher
Oct 27, 2025

Organon CEO Kevin Ali Resigns Amid Audit Probe Into Wholesaler Sales Practices - Stocktwits

Oct 27, 2025
pulisher
Oct 27, 2025

Organon & Co. Announces CEO Changes - MarketScreener

Oct 27, 2025
pulisher
Oct 27, 2025

Organon stock tumbles after CEO resigns amid sales practice investigation By Investing.com - Investing.com UK

Oct 27, 2025
pulisher
Oct 27, 2025

Organon falls as CEO resigns after probe into contraceptive sales - TradingView

Oct 27, 2025
pulisher
Oct 27, 2025

Organon CEO Kevin Ali to resign after probe into wholesaler sales practices - MarketScreener

Oct 27, 2025
pulisher
Oct 27, 2025

Organon Appoints Company Executive Joseph Morrissey as Interim CEO and Board Chair Carrie Cox as Executive Chair; Announces Results of Audit Committee Investigation - Stock Titan

Oct 27, 2025
pulisher
Oct 27, 2025

Co. (7XP) stock considered safe havenMarket Growth Review & Fast Exit and Entry Trade Guides - newser.com

Oct 27, 2025
pulisher
Oct 26, 2025

Bleakley Financial Group LLC Acquires 68,873 Shares of Organon & Co. $OGN - MarketBeat

Oct 26, 2025
pulisher
Oct 26, 2025

Organon & Co. (NYSE:OGN) Given Sell (D+) Rating at Weiss Ratings - MarketBeat

Oct 26, 2025
pulisher
Oct 26, 2025

Allspring Global Investments Holdings LLC Lowers Holdings in Organon & Co. $OGN - MarketBeat

Oct 26, 2025
pulisher
Oct 26, 2025

Co. (7XP) stock survive global slowdown2025 Sector Review & Safe Entry Point Alerts - newser.com

Oct 26, 2025
pulisher
Oct 25, 2025

180 Wealth Advisors LLC Raises Stake in Organon & Co. $OGN - MarketBeat

Oct 25, 2025
pulisher
Oct 24, 2025

Assessing Organon Stock After a 39.5% Drop and Recent Portfolio Moves - Yahoo Finance

Oct 24, 2025
pulisher
Oct 23, 2025

Organon (OGN) Laps the Stock Market: Here's Why - sharewise.com

Oct 23, 2025
drug_manufacturers_general SNY
$50.89
price up icon 0.38%
drug_manufacturers_general PFE
$24.49
price up icon 0.79%
$119.78
price up icon 0.94%
$293.18
price up icon 0.44%
drug_manufacturers_general NVO
$50.24
price down icon 2.19%
drug_manufacturers_general MRK
$85.84
price down icon 0.85%
Capitalizzazione:     |  Volume (24 ore):